Dose Escalation, Not “New Biology,” Can Account for the Efficacy of Stereotactic Body Radiation Therapy With Non-Small Cell Lung Cancer
Brown JM, Brenner DJ, Carlson DJ. Dose Escalation, Not “New Biology,” Can Account for the Efficacy of Stereotactic Body Radiation Therapy With Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2013, 85: 1159-1160. PMID: 23517805, PMCID: PMC3608927, DOI: 10.1016/j.ijrobp.2012.11.003.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerStereotactic body radiation therapyCell lung cancerBody radiation therapyDose escalationLung cancerRadiation therapyTherapyCancer